I would feel much better about a physician who deviated from AI for a justified reason than one who just defaulted to it. There are too many intricacies in complex optical care that won't fit perfectly into a singular algorithm. I'm thinking tear film issues, lifestyle discrepancies, history of healing, or nuanced findings on exam that may outweigh what is printed out. However, AI can still be very useful when it identifies risk sooner, recognizes asymmetry quickly and provides the doctor with a clean baseline. Details matter and that is where human analysis will prevail. What's even better is this approach allows the physician to stay mentally engaged as the tool is advising the decision rather than slowly taking it over. AI should be a fast second set of eyes, never the final voice.
The strategy I return to consistently is treating AI output as a second opinion from a knowledgeable but inexperienced colleague, one who has processed an enormous amount of data but who has never actually sat with a patient. That framing keeps the relationship between algorithm and judgement appropriately calibrated. In complex cases a keratoconus patient where topography and tomography give borderline cross-linking parameters, for instance, or an AMD patient where OCT fluid measurements sit at the margin of treatment thresholds I look specifically for where AI recommendation and clinical impression diverge. That divergence is the most informative signal. It tells me either that there is something I have not fully weighted, or that there is something in the patient's presentation that the algorithm cannot capture. The strategy is documenting that reasoning explicitly: noting what the AI suggested, what my clinical assessment is indicating, and why I chose a certain path. That discipline keeps me honest, supports audit, and over time builds a clearer picture of where AI assistance genuinely adds value in my specific patient population versus where human judgement remains the more reliable guide.
AI is able to present some patterns fast particularly in retinal and visual field examination but in the complex cases of optometry it is a second voice and not the ultimate voice. The best strategy at RGV Direct Care is to make the process slower at the time that the software accelerates it. An AI tool is not to be accepted or rejected when it reminds about potential early glaucoma or diabetic retinopathy alterations. I, instead, cross-reference the recommendation with the full story of the patient. That would be A1C trends, blood pressure history, medication changes and even social factors such as whether they have lost insurance recently and neglected to follow up care. There was a single instance where an algorithm proposed early damage in glaucomatous based on fringe RNFL thinning. The intra-ocular pressure of the patient was stable (14 mmHg) and the appearances of the optic nerve had not deteriorated in the last three years. Stability which was ensured by serial imaging and repeat visual fields more than six months avoids unwarranted medication and anxiety. The AI is helpful in detection of patterns but judgment is made based on longitudinal data and circumstances. The incorporation of technology into a relationship based care model makes sure that decisions remain based on actual human health and not on a flagged piece of data.
I balance AI recommendations with clinical judgment by using a staged-gate governance model so AI is only trusted after objective proof. The strategy I rely on is the Explore-Prove-Scale-Retire gate, where the Prove gate requires measurable criteria before clinical use. At Prove we compare the cost-per-inference to the value of the manual workflow and monitor telemetry like API latency and data drift so clinicians can see when a model is degrading. If those objective signals indicate technical insolvency, the CIO can invoke the kill switch so clinicians revert to judgment and we focus on validated workflows.
At Software House, we built an AI-assisted diagnostic tool for an optometry chain with 25 locations, so I have seen firsthand how clinicians navigate the tension between algorithmic recommendations and their own expertise. The strategy that worked best was what we called the AI-as-second-opinion workflow. Rather than presenting AI findings before the clinician's examination, we designed the system so the optometrist completes their initial assessment first, documents their preliminary findings, and only then reviews the AI analysis. This sequence matters enormously because it prevents anchoring bias. When we initially deployed the tool with AI results shown before the exam, we noticed optometrists were unconsciously steering their examinations to confirm or deny the AI's suggestions rather than conducting their standard comprehensive evaluation. By flipping the order, clinicians maintain their independent judgment and use the AI to catch things they might have missed rather than as a replacement for their clinical thinking. The results validated this approach. In a six-month study across 8,200 patient visits, the AI flagged potential findings that the clinician had not initially noted in about 7 percent of cases. Of those flagged cases, roughly 60 percent turned out to be clinically significant findings that warranted further investigation, including early signs of diabetic retinopathy and subtle visual field changes. But here is the critical part: the AI also generated false positives in about 3 percent of all cases. If clinicians had simply followed every AI recommendation without applying their judgment, it would have resulted in unnecessary referrals and patient anxiety. The optometrists who performed best were those who treated AI disagreements as a prompt to look more carefully rather than as a directive to change their diagnosis. That mindset shift from AI as authority to AI as a careful colleague was the key to making the technology genuinely useful.
I see AI as a helpful support tool, not the final decision-maker. In complex optometric cases, I first review the AI's risk flags or pattern analysis, but I always compare that with the patient's clinical history, imaging results, and the investigator's observations. If the AI suggests a concern, I review the scans again with the clinical team before documenting anything. That short pause helps us confirm whether the finding truly fits the patient's condition. AI speeds up detection, but clinical judgment keeps the interpretation responsible and patient-focused.
In complex cases I treat AI as a second set of eyes rather than the final decision maker. The system can highlight patterns or suggest possibilities based on data, but the clinical judgment still comes from the doctor who understands the patient's full story. A strategy that works well is using AI as a comparison step after my initial assessment. First I review the patient's symptoms, exam results, and images and form my own impression. Then I look at what the AI system suggests. If both line up, it adds confidence to the diagnosis. If they do not match, it becomes a signal to look more carefully at the case. For example, if AI flags something unusual in a retinal image that I did not initially focus on, I go back and review that area more closely. Sometimes it confirms a detail that could have been missed. This approach keeps the human clinical judgment at the center while still benefiting from the pattern recognition that AI can provide. It turns the technology into a helpful support tool rather than something that replaces professional decision making.
AI is most useful in complex optometric cases when it supports the clinician's review instead of replacing it. A strong approach is to treat AI as a second opinion, using it to flag patterns or changes in imaging, then comparing those findings with symptoms, case history, refraction, slit-lamp exam, OCT results, and overall risk factors. A practical strategy is "AI first, clinician final." The optometrist reviews the AI output, then actively checks for gaps or mismatches before making a decision, especially in cases with mixed pathology or poor scan quality. This helps reduce false positives, improves consistency in documentation, and speeds up triage while keeping final judgment with the clinician.
Strategy: Treat AI as a decision-support tool, not the final authority. In complex optometric cases, the most effective approach is to use AI recommendations as a clinical decision-support layer rather than a replacement for professional judgment. AI systems can analyze large datasets and detect patterns in retinal imaging, visual field data, or patient history that may not be immediately obvious. However, these insights must always be interpreted within the broader clinical context. One strategy that works well is cross-validating AI-generated insights with multiple sources of patient data, including imaging results, clinical examination findings, and patient symptoms. If AI suggests a possible diagnosis or risk indicator, clinicians should verify it through additional diagnostic tests or longitudinal patient history before making treatment decisions. The key metric for evaluating the usefulness of AI recommendations is diagnostic consistency and improved clinical workflow, such as faster identification of potential conditions while maintaining high diagnostic accuracy. This approach is effective because it combines the pattern recognition strengths of AI with the nuanced reasoning and contextual judgment of experienced clinicians, ensuring safer and more reliable patient care. — Shri Lakshmi Rajagopal, Quality Engineering & Automation Specialist
Artificial Intelligence (AI) serves as a valuable resource in the practice of optometry; however, it should be treated as a supportive tool instead of an independent decision maker for very complex optometric cases. For maximum benefit, AI should be utilized as a secondary reviewer that can identify patterns or point out additional possibilities, while the clinician uses the complete experience of the patient to make all findings and decisions for the diagnosis and management of the patient's condition. An example of how to use AI in the practice of optometry is through the use of a discordance check, which is a confirmation that triggers a more detailed manual review of the case when there is any disagreement between results generated from AI and data generated by the clinician. By using discordance checks to compare AI-generated results and clinical data, the clinician can identify discrepancies or errors associated with the clinical findings and/or quality of data provided to AI, while ensuring that clinical judgments and decision-making continue to be the primary components in the treatment of all patients.
Balancing AI recommendations with clinical judgment often involves treating AI as an analytical support layer rather than a standalone decision-maker. In complex optometric cases, AI systems can rapidly analyze retinal images, detect subtle patterns, and highlight potential abnormalities, providing valuable diagnostic cues. However, final decisions must integrate patient history, symptoms, and contextual clinical factors that algorithms may not fully capture. Research published by the American Medical Association suggests that AI-assisted diagnostic tools can improve detection accuracy in certain medical imaging scenarios, but human oversight remains essential for safe clinical outcomes. One effective strategy involves using AI outputs as an initial screening mechanism while validating findings through clinical evaluation and professional expertise. This approach combines technological precision with practitioner judgment, ensuring that diagnostic decisions remain both data-informed and clinically grounded.
Balancing AI recommendations with professional judgment often comes down to treating technology as a decision-support tool rather than a final authority. In complex optometric cases, AI can rapidly analyze imaging data and detect patterns that may not be immediately visible, improving diagnostic efficiency. However, clinical expertise remains essential for interpreting those insights within the broader context of patient history, symptoms, and risk factors. Research published by the American Medical Association suggests that AI-assisted diagnostics can improve detection accuracy in certain medical fields, yet human oversight remains critical for final clinical decisions. A practical strategy involves using AI outputs as an initial analytical layer while validating recommendations through clinical reasoning and patient-specific factors. This balanced approach allows technology to enhance diagnostic capability without replacing the nuanced judgment developed through professional experience.
AI is utilized most effectively in complex optometric cases when AI is viewed as a tool to assist rather than a replacement for clinical judgment. AI has the potential to identify patterns or highlight areas of concern prior to the clinician performing the examination. While AI provides possible suggestions regarding pathology that may be present in the retina, the clinician must utilise all the data obtained clinically (i.e. symptoms, history, examination findings, and their clinical experience) in formulating an overall impression of the patient prior to establishing a final diagnosis. One method of using AI to assist with the decision-making process in the optometric office is to have AI assist in early screening and/or pattern recognition; however, that the final decision will remain with the optometrist. For example, if AI identifies possible retinal pathology, the clinician will then use that information to further examine and evaluate additional testing and utilize their clinical judgment to reach a diagnosis. This method allows for greater efficiency while maintaining the integrity of clinical judgment.
Balancing AI recommendations with professional judgment often requires viewing artificial intelligence as a decision-support system rather than a substitute for expertise. In complex clinical scenarios, AI tools can quickly analyze large volumes of diagnostic data and highlight potential risk indicators, offering valuable analytical support. However, interpretation still depends heavily on contextual factors such as patient history, symptoms, and clinical experience. Research from the World Health Organization emphasizes that AI in healthcare delivers the greatest value when combined with human oversight and professional expertise. One effective strategy involves using AI-generated insights as an initial analytical reference, followed by careful validation through expert evaluation and evidence-based reasoning. This balanced approach ensures that technology enhances diagnostic accuracy while preserving the critical role of professional judgment in complex medical decision-making.
I balance AI recommendations with clinical judgment by treating AI as a workflow copilot and making sure the inputs it sees are reliable. One strategy that has worked is to pick a few real patient moments and design the clinical workflow around those use cases so data capture and simple controls are consistent. Start with great inputs and make the tools easy for clinicians to operate without extra technical support. Use AI outputs to inform and streamline decisions, but keep final judgment firmly with the clinician.
Artificial Intelligence (AI) Must Serve as A Support, NOT REPLACEMENT for Clinical Assessment in Complex Optometric Cases. To Be as Safe as Possible, All AI Recommendations Must Be Compared with The Totality of Clinical Data Prior To Making An Informed Decision. Clinical Data Includes All Clinical Findings; Results from Imaging Studies; Documented Patient History; And Documented Symptoms Consistent with The Patient's Examination Data. The Best Way to Build this Safeguard/Check is to Include a-Mandatory Staff Review of Each Software Result Prior to Any Clinical Based Decision Making For Each Results. Including a Required Staff Review Will Provide The Opportunity to Verify That The Software Output is Consistent with The Overall Clinical Data and Not Just Relied Upon as An Autonomous Decision-Making Process that Could Be Misleading If The Software Output is Incorrect Due or to Low Quality Images or Falsely Reported Symptoms by the Patient That Do Not Fit The AI Software Output.